System and method for image guidance during medical procedures

ABSTRACT

A surgical guidance system is disclosed that allows for real-time imaging and patient monitoring during a surgical procedure. The system can include an MRI system for generating real-time images of the patient while surgery is being performed. Prior to surgery, a surgical plan can be created using a planning interface. A control unit receives the real-time image data and the surgical plan, and monitors the image data based on parameters included in the surgical plan. The control-unit monitoring occurs in real-time while the surgical procedure is being performed. The control unit can detect deviations from the surgical plan and/or high-risk patient conditions and instruct an alert unit to issue an alert based on the detected conditions.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation and claims the benefit of priorityunder 35 U.S.C. §120 of U.S. patent application Ser. No. 14/332,839,filed Jul. 16, 2014, entitled “System And Method For Image GuidanceDuring Medical Procedures”, which claims the benefit of priority of U.S.patent application Ser. No. 13,333/726, filed Dec. 21, 2011, entitled“System And Method For Image Guidance During Medical Procedures”, whichclaims the benefit of priority under 35 U.S.C. §119 of U.S. ProvisionalApplication No. 61/425,891, filed Dec. 22, 2010, entitled “Devices AndMethods For Real-Time Image Guidance To Assist In Surgical Procedures”.The disclosures of these documents are incorporated herein by referencein their entirety for all purposes.

BACKGROUND 1. Technical Field

The present disclosure relates to medical systems and methods, and moreparticularly to systems and methods for imaging the anatomy of a patientduring medical treatment, particularly where the resulting images can beused for enhancing the medical treatment.

2. Related Art

Many types of medical treatments involve a pre-treatment planning phase.Examples of medical treatments may include such things as medications,physical therapy, radiation treatment, and/or surgical procedures.Pre-treatment planning may include medical imaging of patient anatomy,such as x-ray, computed tomography (CT), and/or magnetic resonanceimaging (MRI). The images can then be used to assist a physician withdeciding on a course of treatment, and preparing a detailed plan forcarrying out the medical treatment.

For example, where a medical treatment involves a surgical procedure, asurgical plan is commonly prepared prior to performing the actualsurgery. In some cases, a patient undergoes some form of preoperativemedical imaging so that the surgical team can review images of thepatient's anatomy as part of the surgical planning process. Also, insome cases the preoperative images can be used during the surgicalprocedure. Image-guided surgery (IGS) is a general term used for asurgical procedure where the surgeon can employ tracked surgicalinstruments in conjunction with preoperative or intraoperative planarimages in order to indirectly guide the procedure. Most image-guidedsurgical procedures are minimally invasive.

Surgery can include, but is not limited to, any one or more of thefollowing procedures:

Incision—puncturing or cutting into an organ, tumor, or other tissue.

Excision—cutting out an organ, tumor, or other tissue.

Resection—partial removal of an organ or other bodily structure.

Reconnection of organs, tissues, etc., particularly if severed.Resection of organs, such as intestines, typically involvesreconnection. Internal suturing or stapling may be used for thereconnection. Surgical connection between blood vessels or other tubularor hollow structures, such as loops of intestine, is called anastomosis.

Ligation—tying off blood vessels, ducts, or “tubes.”

Grafting—severing pieces of tissue cut from the same (or different)body, or flaps of tissue still partially connected to the body, butresewn for rearranging or restructuring of an area of the body inquestion. Although grafting is often used in cosmetic surgery, it isalso used in other surgery. Grafts may be taken from one area of thepatient's body and inserted to another area of the body. An example isbypass surgery, where clogged blood vessels are bypassed with a graftfrom another part of the body. Alternatively, grafts may be from otherpersons, cadavers, or animals.

Insertion of prosthetic parts. Examples of prosthetic parts can includepins or screws for setting and holding together bones; prosthetic rodsor other prosthetic parts for replacing sections of bone; plates thatare inserted to replace a damaged area of a skull; so-called artificialparts, for example artificial hips, used to replace damaged anatomy;heart pacemakers or valves; or many other types of known prostheses.

Creation of a stoma, which is a permanent or semi-permanent opening inthe body.

Organ or tissue transplantation, where a donor organ (taken out of adonor's body) is inserted into a recipient's body and connected to therecipient in all necessary ways (blood vessels, ducts, etc.).

Arthrodesis—surgical connection of adjacent bones so the bones can growtogether into one. Spinal fusion is an example of arthrodesis, whereadjacent vertebrae are connected allowing them to grow together into onepiece.

Modification of tissues, e.g., the digestive tract in bariatric surgeryfor weight loss.

Repair of a fistula, hernia, stoma, or prolapse.

Ablation or destruction of tissues through the use of heat, cold,electrical current, radiation, or other cell-trauma inducing technology.

Angioplasty, endoscopy, or implantation of devices.

Clearing clogged ducts, blood or other vessels.

Removal of calculi (stones).

Draining of accumulated fluids.

Debridement, which involves the removal of dead, damaged, or diseasedtissue.

Exploration to aid or confirm a diagnosis.

Sampling of tissue to aid or confirm a diagnosis.

Amputation, replantation, or reconstruction of tissues or organs.

Some conventional ICS systems include a planar imaging system and ahand-held surgical probe. The planar imaging system is used to take apreoperative or intraoperative “snap shot” of the patient's anatomy inorder to locate the patient's anatomy and plan the surgical procedure.During the surgical procedure, some IGS systems include the ability totrack the surgical probe position relative to the planar, static image.In such cases, the IGS system includes a display for displaying thestatic image beneath an image representative of the surgical probe. Insome IGS systems, the probe location can be displayed over patientanatomy, where patient anatomy is displayed as three orthogonal, planarimage slices on a workstation-based 3D imaging system.

An example of an IGS system is StealthStation®, which is a productoffered by Medtronic, Inc. The Medtronic StealthStation® IGS systemutilizes electromagnetic and optical tracking technology to determinethe location of surgical instruments within a patient during a surgicalprocedure. The system uses previously-prepared coregistered sectional2-D images, which are combined using known algorithms to produce 3-Dimages. The system can then superimpose the position of the instrumentover the images so that the surgeon can observe the location of theinstrument during a surgical procedure. Such IGS systems may use any ofa variety of different tracking techniques, including mechanical,optical, ultrasonic, and electromagnetic technologies to track the proberelative to the static images. Such systems have followed a paradigmwhere the patient's anatomy is assumed to be static and unmoving duringa surgical procedure, and the focus has been attempting to track the“proper” location of the surgical probe or instrument. Such systems alsoassume that the surgeon will be observing the images, rather than thepatient, while positioning the instrument.

As mentioned above, references to treatments can also include medicaltreatments other than those involving surgical procedures. Anotherexample of a medical treatment is radiation therapy. For example,disease caused by proliferative tissue disorders such as cancer andcoronary artery restenosis are sometimes treated with radiation, wherethe portions of the patient known to contain or suspected to containdisease are irradiated. For this purpose, a radiotherapy planning systemis used to first acquire planning images of the diseased portion(s) andsurrounding regions.

Radiotherapy planning systems generally include a CT or MRI simulator.CT or MRI radiography is carried out, typically on a single day, beforethe beginning of therapy to acquire a plurality of coregisteredsectional 2-D images. These sectional images are combined using knownalgorithms to produce 3-D images. These 3-D simulation images aredisplayed and then analyzed to identify the location of regions ofsuspected disease to be treated, such as a radiographically evidenttumor or regions suspected of microscopic disease spread. These regionsto be treated are called radiotherapy targets.

In order to attempt to account for organ motions, the concept of marginsand planning target volumes (PTVs) was developed to attempt to irradiatea volume that would hopefully contain the target during most of theirradiation. PTVs include a geometric margin to account for variationsin patient geometry or motion. Likewise, the 3-D simulation images aredisplayed and then analyzed to identify important normal anatomy andtissues that may be damaged by the radiation, such as the spinal cordand lung, to evaluate the potential impact of radiation on the functionof these tissues. These regions to be spared or protected from excessiveradiation are called critical structures or organs at risk and may alsoinclude a margin to account for variations in patient geometry ormotion. The delivery of radiation therapy is then traditionally plannedon a single static model of radiotherapy targets and critical structuresderived from a single set of CT and/or MRI images.

Because the known art does not allow for simultaneous volumetric imagingand therapy, the patient and all of their internal organs need to berepositioned exactly for accurate IGS or radiation dose delivery.However, it is known in the art that exactly repositioning the patientis not possible due to several factors including: the inability toreproduce the patient setup, i.e., the geometry and alignment of thepatient's body; physiological changes in the patient, such as weightloss or tumor growth and shrinkage; and organ motions in the patientsincluding but not limited to breathing motion, cardiac motion, rectaldistension, peristalsis, bladder filling, and voluntary muscular motion.Note that the organ motions may occur on rapid time scales such thatchanges may occur during a single dose delivery (e.g., breathingmotion), termed “intra-fraction” organ motions, or they may occur onslower time scales such that changes occur in between dose deliveries orsurgical procedures, termed “inter-fraction” organ motions.

In both the fields of surgery and radiation therapy, patient setuperrors, physiological changes, and organ motions result in increasingmisalignment of the tracked surgical instrument or treatment beamsrelative to the anatomical targets and critical structures of a patientas the surgery or radiotherapy process proceeds.

For example, in the field of radiation therapy, for years practitionershave been acquiring hard-copy films of the patient using the radiationtherapy beam, technically referred to as a “port film,” to attempt toensure that the beam position does not significantly vary from theoriginal plan. However, the port films acquired are generally onlysingle 2-D projection images taken at some predetermined interval duringthe radiotherapy process (typically 1 week). Port films cannot accountfor organ motion. Additionally, port films do not image soft tissueanatomy with any significant contrast, and only provide reliableinformation on the honey anatomy of the patient. Accordingly,misalignment information is only provided at the instants in time inwhich the port images are taken, and may be misleading as the honeyanatomy and soft tissue anatomy alignment need not correlate and changewith time. With appropriate markers in the port image provided, the beammisalignment may be determined and then corrected to some limiteddegree.

More recently, some have disclosed acquiring the port imageselectronically, referred to as electronic portal imaging. This imagingtechnique employs solid state semiconductor, scintillator, or liquidionization chamber array technology to capture x-ray transmissionradiographs of the patient using the x-rays of the linear accelerator oran associated kilovoltage x-ray unit. As with the hard-copy technique,misalignment data is only provided at the instants in time in which theport images are taken. Another recent advance in electronic portalimaging includes the use of implanted interstitial radio-opaque markersin an attempt to image the location of soft tissues. These proceduresare invasive and subject to marker migration. Even when performed withthe rapid acquisition of many images, these procedures only result infinding the motion of discrete points identified by the radio-opaquemarkers inside a soft tissue, and cannot account for the truecomplexities of organ motions and the dosimetric errors that they cause.Another recent advance involves the acquisition of a volumetriccone-beam x-ray CT image set or a helical tomotherapy megavoltage x-rayCT image set before or after a daily delivery of radiation therapy,where the image set can be used to create 3D volumetric image sets fromthe 2D electronic portal images. While this technology may account forsome patient setup errors, such as the geometry and alignment of thepatient's body, physiological changes in the patient, and inter-fractionorgan motions in the patient, it cannot account for intra-fraction organmotions in the patients. Intrafraction organ motions are very importantand include, but are not limited to, breathing motion, cardiac motion,rectal gas distension, peristalsis, bladder filling, and voluntarymuscular motion.

Radiation therapy has historically been delivered to large regions ofthe body including the target volume. While some volume margin isrequired to account for the possibility of microscopic disease spread,much of the margin is required to account for uncertainties in treatmentplanning and delivery of radiation. Reducing the total volume of tissueirradiated is beneficial, since this reduces the amount of normal tissueirradiated and therefore reduces the overall toxicity to the patientfrom radiation therapy. Furthermore, reduction in overall treatmentvolume may allow dose escalation to the target, thus increasing theprobability of tumor control.

Clinical cobalt (⁶⁰Co radioisotope source) therapy units and MY linearaccelerators (or linacs) were introduced nearly contemporaneously in theearly 1950's. The first two clinical cobalt therapy units were installednearly simultaneously in October of 1951 in Saskatoon and London,Ontario. The first MV linear accelerator installed solely for clinicaluse was at Hammersmith Hospital in London, England, in June of 1952. Thefirst patient was treated with this machine in August of 1953. Thesedevices soon became widely employed in cancer therapy. The deeplypenetrating ionizing photon beams quickly became the mainstay ofradiation therapy, allowing the widespread noninvasive treatment of deepseated tumors. The role of X-ray therapy slowly changed with the adventof these devices from a mainly palliative therapy to a definitivecurative therapy. Despite similarities, cobalt units and linacs werealways viewed as rival technologies in external beam radiotherapy. Thisrivalry would result in the eventual dominance of linacs in the UnitedStates and Western Europe.

The cobalt unit was quite simplistic and was not technically improvedsignificantly over time. Of course, the simplicity of the cobalt unitwas a cause for some of its appeal; the cobalt units were very reliable,precise, and required little maintenance and technical expertise to run.Early on, this allowed cobalt therapy to become the most widespread formof external beam therapy.

[The linac was the more technically intensive device. Linacs werecapable of accelerating high currents of electrons to energies between 4and 25 MeV to produce beams of bremsstrahlung photons or scatteredelectrons. As such, the linac was a much more versatile machine thatallowed more penetrating beams with sharper penumbrae and higher doserates. As the linac became more reliable, the benefits of having morepenetrating photon beams coupled with the addition of electron beams wasseen as strong enough impetus to replace the existing cobalt units.

[Cobalt therapy did not die away without some protests, and the essenceof this debate was captured in a famous paper in 1986 by Laughlin,Mohan, and Kutcher, which explained the pros and cons of cobalt unitsand linacs. This was accompanied by an editorial from Suit that pleadedfor the continuance and further technical development of cobalt units.The pros of cobalt units and linacs have already been listed. The consof cobalt units were seen as less penetrating depth dose, largerpenumbra due to source size, large surface doses for large fields due tolower energy contamination electrons, and mandatory regulatoryoversight. The cons for linacs increased with their increasing energy(and hence their difference from a low energy cobalt beam), and wereseen to be increased builddown, increased penumbra due to electrontransport, increased dose to bone (due to increased dose due to pairproduction), and most importantly the production of photo-neutrons atacceleration potentials over 10 MV.

In the era before intensity modulated radiation therapy (IMRT), thelinac held definite advantages over cobalt therapy. The fact that onecould produce a very similar beam to cobalt using a 4 MV linacaccelerating potential combined with the linac's ability to produceeither electron beams or more penetrating photon beams, made the linacpreferable. When the value of cobalt therapy was being weighed againstthe value linac therapy, radiation fields were only manually developedand were without the benefit of IMRT. As IMRT has developed, the use ofhigher MY linac accelerating potential beams and electron beams havebeen largely abandoned by the community. This is partly due to theincreased concern over neutron production (and increased patient wholebody dose) for the increased beam-on times required by IMRT and thecomplexity of optimizing electron beams, but most importantly becauselow MY photon-beam IMRT could produce treatment plans of excellentquality for all sites of cancer treatment.

IMRT represents a culmination of decades of improving 3D dosecalculations and optimization to the point that we have achieved a highdegree of accuracy and precision for static objects. However, there is afundamental flaw in our currently accepted paradigm for dose modeling.The problem lies with the fact that patients are essentially dynamicdeformable objects that we cannot and will not perfectly reposition forfractioned radiotherapy. Even for one dose delivery, intra-fractionorgan motion can cause significant errors. Despite this fact, thedelivery of radiation therapy is traditionally planned on a static modelof radiotherapy targets and critical structures. The real problem liesin the fact that outside of the cranium (i.e., excluding the treatmentof CNS disease using Stereotactic radiotherapy) radiation therapy needsto be fractionated to be effective, i.e., it must be delivered in single1.8 to 2.2 Gy fractions or double 1.2 to 1.5 Gy fractions daily, and istraditionally delivered during the work week (Monday through Friday),taking 7 to 8 weeks to deliver a curative dose of 70 to 72 Gy at 2.0 or1.8 Gy, respectively. This daily fractionation requires the patient andall of their internal organs to be repositioned exactly for accuratedose delivery. This raises an extremely important question for radiationtherapy: “Of what use is all of the elegant dose computation andoptimization we have developed if the targets and critical structuresmove around during the actual therapy?” Recent critical reviews of organmotion studies have summarized the existing literature up to 2001 andhave shown that the two most prevalent types of organ-motion: patientset-up errors and organ motions. While significant physiological changesin the patient do occur, e.g., significant tumor shrinkage inhead-and-neck cancer is often observed clinically, they have not beenwell studied. Organ motion studies have been further subdivided intointer-fraction and intra-fraction organ motion, with the acknowledgementthat the two cannot be explicitly separated, i.e., intra-fractionmotions obviously confound the clean observation of inter-fractionmotions. Data on inter-fraction motion of gynecological tumors,prostate, bladder, and rectum have been published, as well as data onthe intra-fraction movement of the liver, diaphragm, kidneys, pancreas,lung tumors, and prostate. Many peer-reviewed publications, spanning thetwo decades prior to publication have demonstrated the fact that bothinter- and intra-fraction organ motions may have a significant effect onradiation therapy dosimetry. This may be seen in the fact thatdisplacements between 0.5 and 4.0 cm have been commonly observed instudies of less than 50 patients. The mean displacements for manyobservations of an organ motion may be small, but even an infrequent yetlarge displacement may significantly alter the biologically effectivedose received by a patient, as it is well accepted that the correct doseper fraction must be maintained to effect tumor control. In a morefocused review of intra-fraction organ motion recently published byGoitein (Seminar in Radiation Oncology 2004 January; 14(1):2-9), theimportance of dealing with organ motion related dosimetry errors wasconcisely stated: “[I]t is incontestable that unacceptably, or at leastundesirably, large motions may occur in some patients . . . .” It wasfurther explained by Goitein that the problem of organ motions hasalways been a concern in radiation therapy: “We have known that patientsmove and breathe and that their hearts beat and their intestines wrigglesince radiation was first used in cancer therapy. In not-so-distantdecades, our solution was simply to watch all that motion on thesimulator's fluoroscope and then set the field edge wires wide enoughthat the target (never mind that we could not see it) stayed within thefield.”

In an attempt to address the limitations imposed on radiation therapy bypatient setup errors, physiological changes, and organ motion throughoutthe protracted weeks of radiation therapy, imaging systems have beenintroduced that are capable of acquiring a volumetric CT “snap shot”before and after each delivery of radiation. This combination of aradiation therapy unit with radiology imaging equipment has been termedimage-guided radiation therapy (IGRT), or preferably image guided IMRT(IGIMRT). IGIMRT technology has the potential for removing patient setuperrors, detecting slow physiological changes, and detectinginter-fraction organ motions that occur over the extended course ofradiation therapy. However, IGIMRT technology cannot account forintra-fraction organ motion, which is a very significant form of organmotion. IGIMRT devices are only being used to shift the gross patientposition. IGIMRT devices cannot capture infra-fraction organ motion andare limited by the speed at which helical or cone-beam CT imaging may beperformed. Secondly, but perhaps equally important, CT imaging adds tothe ionizing radiation dose delivered to the patient. It is well knownthat the incidence of secondary carcinogenesis occurs in regions oflow-to-moderate dose, and the whole body dose will be increased by theapplication of many CT image studies.

CT imaging and MRI units were both demonstrated in the 1970's. CTimaging was adopted as the “gold standard” for radiation therapy imagingearly on due to its intrinsic spatial integrity, which comes from thephysical process of X-ray attenuation. Despite the possibility ofspatial distortions occurring in MRI, it is still very attractive as animaging modality for radiotherapy. MRI has a much better soft tissuecontrast than CT imaging, and has the ability to image physiological andmetabolic information, such as chemical tumor signals or oxygenationlevels. The MRI artifacts that influence the spatial integrity of thedata are related to undesired fluctuations in the magnetic fieldhomogeneity and may be separated into two categories: 1) artifacts dueto the scanner, such as field inhomogeneities intrinsic to the magnetdesign, and induced eddy currents due to gradient switching; and 2)artifacts due to the imaging subject, i.e., the intrinsic magneticsusceptibility of the patient. Modem MRI units are carefullycharacterized and employ reconstruction algorithms that may effectivelyeliminate artifacts due to the scanner. At high magnetic field strength,in the range of 1.0-3.0 T, magnetic susceptibility of the patient mayproduce significant distortions (which are proportional to fieldstrength) that may often be eliminated by first acquiring susceptibilityimaging data. Recently, many academic centers have started to employ MRIfor radiation therapy treatment planning. Rather than dealing withpatient-related artifacts at high field strength, many radiation therapycenters have employed low-field MRI units with 0.2-0.3 T for radiationtherapy treatment planning, as these units diminishpatient-susceptibility spatial distortions to insignificant levels. Fordealing with intra- fraction organ motion, MRI is highly favorable dueto the fact that it is fast enough to track patient motions inreal-time, has an easily adjustable and orientable field of view, anddoes not deliver any additional ionizing radiation to the patient thatmay increase the incidence of secondary carcinogenesis.Breath-controlled and spirometer-gated fast multi-slice CT has recentlybeen employed in an attempt to assess or model intra-fraction breathingmotion by many research groups. Fast, single-slice MRI has also beenemployed in the assessment of intra-fraction motions, and dynamicparallel MRI is able to perform volumetric intra-fraction motionimaging. MRI holds a definite advantage over CT for fast repetitiveimaging due to the need for CT imaging to deliver increasing doses tothe patient. Concerns over increased secondary carcinogenesis due towhole-body dose already exist for IMRT and become significantly worsewith the addition of repeated CT imaging.

Two research groups appear to have simultaneously been attempting todevelop an MRI unit integrated with a linac. In 2001, U.S. Pat. No.6,198,957 was issued to Green, which teaches an integrated MRI and linacdevice. In 2003, a group from the University of Utrecht in theNetherlands presented their design for an integrated MRI and linacdevice, and has since reported dosimetric computations to test thefeasibility of their device. The significant difficulty with integratingan MRI unit with a linac, as opposed to a CT imaging unit, is that themagnetic field of the MRI unit makes the linac inoperable. It is wellknown that a charged particle moving at a velocity, v, in the presenceof a magnetic field B, experiences a Lorentz force given by F=v×B. TheLorentz force caused by the MRI unit will not allow electrons to beaccelerated by the linac as they cannot travel in a linear path,effectively shutting the linac off. The high radiofrequency (RF)emittance of the linac will also cause problems with the RF transceiversystem of the MRI unit, corrupting the signals required for imagereconstruction and possibly destroying delicate circuitry. Theintegration of a linac with a MRI unit is a monumental engineeringeffort and has not previously been enabled.

Intensity modulated radiation therapy (IMRT) is a type of external beamtreatment that is able to conform radiation to the size, shape, andlocation of a tumor. IMRT is a major improvement as compared to otherconventional radiation treatments. The radiotherapy delivery method ofIMRT is known in the art of radiation therapy and is described in a bookby Steve Webb entitled “Intensity-Modulated Radiation Therapy” (IOPPublishing, 2001, ISBN 0750306998). This work of Webb is incorporated byreference into the application in its entirety and hereafter referred toas “Webb 2001.” The effectiveness of conventional radiation therapy islimited by imperfect targeting of tumors and insufficient radiationdosing. Because of these limitations, conventional radiation may exposeexcessive amounts of healthy tissue to radiation, thus causing negativeside-effects or complications. With IMRT, the optimal 3D dosedistribution, as defined by criteria known in the art (such as disclosedby Webb 2001), is delivered to the tumor and dose to surrounding healthytissue is minimized.

In a typical IMRT treatment procedure, the patient undergoes treatmentplanning x-ray CT imaging simulation with the possible addition of MRIsimulation or a position emission tomography (PET) study to obtainmetabolic information for disease targeting. When scanning takes place,the patient is immobilized in a manner consistent with treatment so thatthe imaging is completed with the highest degree of accuracy. Aradiation oncologist or other affiliated health care professionaltypically analyzes these images and determines the 3D regions that needto be treated and 3D regions that need to be spared, such as criticalstructures, e.g. the spinal cord and surrounding organs. Based on thisanalysis, an IMRT treatment plan is developed using large-scaleoptimization.

IMRT relies on two advanced technologies. The first is inverse treatmentplanning. Through sophisticated algorithms using high speed computers, atreatment plan can be determined using an optimization process. Thetreatment plan is intended to deliver a prescribed uniform dose to atumor while minimizing excessive exposure to surrounding healthy tissue.During inverse planning a large number (e.g. several thousands) ofpencil beams or beamlets that comprise the radiation beam areindependently targeted to the tumor or other target structures with highaccuracy. Through optimization algorithms, the non-uniform intensitydistributions of the individual beamlets are determined to attaincertain specific clinical objectives.

The second technology relied on for IMRT involves the used of multi-leafcollimators (MLC). MLC technology allows for delivery of the treatmentplan derived from the inverse treatment planning system. A separateoptimization, referred to as leaf sequencing, is used to convert the setof beamlet fluences to an equivalent set of leaf motion instructions orstatic apertures with associated fluences. The MLC is typically composedof computer-controlled tungsten leaves that shift to form specificpatterns, thereby blocking the radiation beams according to theintensity profile from the treatment plan. As an alternative to MLCdelivery, an attenuating filter may also be designed to match thefluence of beamlets.

After the treatment plan is generated and quality control checking hasbeen completed, the patient is immobilized and positioned on thetreatment couch. Positioning of the patient includes attempting toreproduce the patient positioning from during the initial x-ray CT ormagnetic resonance imaging. Radiation is then delivered to the patientvia the MLC instructions or attenuation filter. This process is thenrepeated for many weeks until the prescribed cumulative dose is assumedto be delivered.

Magnetic resonance imaging (MRI) is an advanced diagnostic imagingprocedure that creates detailed images of internal bodily structureswithout the use of ionizing radiation, which is used in x-ray ormegavoltage x-ray CT imaging. The diagnostic imaging method of MRI isknown in the arts of radiology and radiation therapy and is described inthe books by E. M. Haacke, R. W. Brown, M. R. Thompson, R. Venkatesanentitled Magnetic Resonance Imaging: Physical Principles and SequenceDesign (John Wiley & Sons, 1999, ISBN 0-471-35128-8) and by Z.-P. Liangand P. C. Lauterbur entitled Principles of Magnetic Resonance Imaging: ASignal Processing Perspective. (IEEE Press 2000, ISBN 0-7803-4723-4).These works of Haacke et al. and Liang and Lauterbur are incorporatedherein by reference in their entirety, and are hereafter referred to as“Haacke et al. 1999” and “Liang and Lauterbur 2001,” respectively. MRIis able to produce detailed images through the use of a powerful mainmagnet, magnetic field gradient system, radiofrequency (RE) transceiversystem, and an image reconstruction computer system. Open MagneticResonance Imaging (Open MRI) is an advanced form of MRI diagnosticimaging that uses a main magnet geometry that does not completelyenclose the patient during imaging. MRI is a very attractive imagingmodality for radiotherapy as it has a much better soft tissue contrastthan CT imaging and the ability to image physiological and metabolicinformation, such as spectroscopic chemical tumor signals or oxygenationlevels. Many tracer agents exist and are under development for MRI toimprove soft tissue contrast (e.g. Gadopentate dimeglumine for kidney orbowel enhancement, or Gadoterate meglumine for general contrast). Novelcontrast agents are currently under development that will allow for themetabolic detection of tumors, similar to PET imaging, by employingeither hyperpolarized liquids containing carbon 13, nitrogen 15, orsimilar stable isotopic agents or paramagnetic niosomes. All of thesediagnostic MRI techniques enhance the accurate targeting of disease andhelp assess response to treatment in radiation therapy.

CT scanning for IMRT treatment planning is performed using thin sections(2-3 mm), sometimes after intravenous injection of an iodine-containingcontrast medium. CT scanning has the advantage of being more widelyavailable, cheaper than magnetic resonance imaging (MRI), and it may becalibrated to yield electron density information for treatment planning.Some patients who cannot be examined by MRI (due to claustrophobia,cardiac pacemaker, aneurism clips, etc.) may be scanned by CT.

The problem of patient setup errors, physiological changes, and organmotions during various medical treatments, including radiation treatmentand IGS, is currently a topic of great interest and significance. Forexample, in the field of radiology, it is well known that the accuracyof conformal radiation therapy is significantly limited by changes inpatient mass, location, orientation, articulated geometricconfiguration, and inter-fraction and intra-fraction organ motions (e.g.during respiration), both during a single delivery of dose(intrafraction changes, e.g., organ motions such as rectal distension bygas, bladder filling with urine, or thoracic breathing motion) andbetween daily dose deliveries (interfraction changes, e.g.,physiological changes such as weight gain and tumor growth or shrinkage,and patient geometry changes). No single effective method has previouslybeen known to account for all of these deviations simultaneously duringeach and every actual dose delivery. Current state-of-the-art imagingtechnology allows taking 2D and 3D megavoltage and orthovoltage x-ray CT“snap-shots” of patients before and after a medical treatment, or mayallow for taking time-resolved 2D radiographs that have no soft tissuecontrast during radiation delivery.

Great advances have been made in a number of medical fields that involvevarious types of medical therapies, including conformal radiationtherapy and IGS. However, their true efficacy is not realized withoutimproved real-time imaging guidance and control.

SUMMARY

The present disclosure includes detailed descriptions of embodimentsthat allow for real-time monitoring of patient anatomy during varioustypes of medical treatments. For example, disclosed embodiments caninclude a device and/or a process for performing high temporal- andspatial-resolution magnetic resonance imaging (MRI) of the anatomy andtarget tissues of a patient during various forms of medical therapy,which can include, for example, radiation therapy and/or various typesof surgical procedures.

According to one aspect of the present disclosure, a surgical guidancesystem can comprise a magnetic resonance imaging (MRI) system configuredfor generating MRI data representative of a portion of a patient, aplanning interface for generating a surgical plan based at least in parton pre-surgical images and input information regarding surgicalparameters for a surgical procedure, a control unit for receiving imagedata based on the MRI data acquired during the surgical procedure andfor monitoring the image data for conditions included in the surgicalparameters of the surgical plan, and an alert unit for issuing an alertbased on instructions from the control unit, wherein the control unit isconfigured to instruct the alert unit to issue the alert based ondetecting at least one of the conditions included in the surgicalparameters of the surgical plan.

The MRI can include first and second main magnets separated by a gap.The MRI system can be configured for generating MRI data representativeof the portion of the patient positioned in the gap.

The MRI can be configured such that images may be captured substantiallysimultaneously with performance of the surgical procedure. The controlunit can be configured to employ the image data for monitoring patient'sresponse to the surgical procedure substantially simultaneously withperformance of the surgical procedure. The monitoring of the patient'sresponse to the surgical procedure can include monitoring changes to thepatient's anatomy substantially simultaneously with performance of thesurgical procedure. The control unit can be configured to instruct thealert unit to issue the alert during the surgical procedure based ondetecting at least one condition associated with the changes to thepatient's anatomy.

The surgical guidance system can further comprise a tracking unit fortracking a surgical instrument used for performing the surgicalprocedure.

The surgical guidance system can further comprise a tracking unit fortracking a surgical robotic device performing the surgical procedure.

The alert unit can be configured to issue the alert in the form of atleast one of visual information and audible information.

The surgical guidance system may further comprise an image processingunit for receiving the MRI data from the MRI system and generating imagedata based on the MRI data. The MRI system can be configured forobtaining MRI data representative of a first quality of images beforethe start of the surgical procedure, and for obtaining MRI datarepresentative of a second quality of images during substantiallysimultaneous performance of the surgical procedure, the second qualitybeing lower than the first quality. The image processing unit can beconfigured for generating image data representative of volumetric imagesfrom MRI data generated during the obtaining of MRI data representativeof the second quality of images, wherein the generating of the imagedata representative of volumetric images can include using deformableimage registration.

The image processing unit can be configured for generating image datarepresentative of volumetric images based on the MRI data received fromthe MRI system. The image processing unit can be configured forgenerating the image data representative of volumetric images usingdeformable image registration.

According to another aspect of the present disclosure, a surgicalguidance system can comprise an MRI system configured for generating MRIdata representative of a portion of a patient substantiallysimultaneously with performance of a surgical procedure on the patient.The surgical guidance system can also comprise a control unit forreceiving image data representative of volumetric images based on theMRI data acquired during the surgical procedure and for monitoring theimage data for predetermined conditions, and an alert unit for issuingan alert based on instructions from the control unit. The control unitcan be configured to instruct the alert unit to issue the alert based ondetecting at least one of the predetermined conditions.

The surgical guidance system can further comprise a planning interfacefor receiving at least one of the predetermined conditions.

The MRI can be configured such that images may be captured substantiallysimultaneously with performance of the surgical procedure. The controlunit can be configured to employ the image data for monitoring patient'sresponse to the surgical procedure substantially simultaneously withperformance of the surgical procedure. The monitoring of the patient'sresponse to the surgical procedure can include monitoring changes to thepatient's anatomy substantially simultaneously with performance of thesurgical procedure.

The control unit can be configured to instruct the alert unit to issuethe alert during the surgical procedure based on detecting at least onecondition associated with the changes to the patient's anatomy.

The surgical guidance system can further comprise an image processingunit for receiving MRI data from the MRI system and generating imagedata representative of the volumetric images based on the MRI data. TheMRI system can be configured for obtaining MRI data representative of afirst quality of images before the start of the surgical procedure, andobtaining MRI data representative of a second quality of images duringsubstantially simultaneous performance of the surgical procedure, thesecond quality being lower than the first quality. The image processingunit can be configured for generating image data representative of thevolumetric images from MRI data generated during the obtaining of MRIdata representative of the second quality of images, wherein thegenerating of the image data representative of volumetric images caninclude using deformable image registration.

The image processing unit can be configured for generating image datarepresentative of the volumetric images using deformable imageregistration.

According to a further aspect of the present disclosure, a surgicalguidance a surgical guidance method comprises generating MRI datarepresentative of a portion of a patient; generating image data based onthe MRI data; generating a surgical plan based at least in part onpre-surgical images and input information regarding surgical parametersfor a surgical procedure; monitoring the image data for conditionsincluded in the surgical parameters of the surgical plan; and issuing analert based on detecting at least one of the conditions included in thesurgical parameters of the surgical plan. The image data can berepresentative of volumetric images based on the MRI data.

These and other features, aspects, and embodiments are described belowin the section entitled “Detailed Description of the Drawings.”

BRIEF DESCRIPTION OF DRAWINGS

There are shown in the drawings, embodiments which are presentlycontemplated, it being understood, however, that the present disclosureis not limited to the precise arrangements and instrumentalities shown.

FIG. 1 shows a schematic view of a radiation therapy system according tothe present disclosure;

FIG. 2 shows another schematic view of the radiation therapy systemshown in FIG. 1, where a radiation source and collimator have beenrotated from the position shown in FIG. 1;

FIG. 3 shows a top view of the radiation therapy system shown in FIG. 1;

FIG. 4 shows a side view of the radiation therapy system shown in FIG.1;

FIG. 5 shows a detailed schematic view of the co-registered isotopicradiation source of the radiation therapy system shown in FIG. 1;

FIG. 6 shows a perspective view of collimators of the radiation therapysystem shown in FIG. 1;

FIG. 7 shows a beams-eye view of the radioisotopic source andcollimators of the radiation therapy system shown in FIG. 1;

FIG. 8 shows axial dose distributions from a single head-and-neck IMRTcase planned using commissioned cobalt beamlets;

FIG. 9 shows DVH data derived from the single head-and-neck IMRT caseshown in FIG. 8;

FIG. 10 shows cobalt beamlet dose distributions in water with andwithout a 0.3 Tesla magnetic field;

FIG. 11 shows cobalt beamlets dose distributions in water and lungs withand without a 0.3 Tesla magnetic field;

FIG. 12 shows cobalt beamlets dose distributions in water and air withand without a 0.3 Tesla magnetic field;

FIG. 13 shows a block diagram of a surgical guidance system according tothe present disclosure;

FIG. 14 shows a perspective view of an embodiment of the surgicalguidance system shown in FIG. 13; and

FIG. 15 shows a perspective view of an alternative embodiment of thesurgical guidance system shown in FIG. 13.

DETAILED DESCRIPTION OF THE DRAWINGS

Aspects of the present disclosure are more particularly described in thefollowing examples that are intended to be illustrative only sincenumerous modifications and variations therein will be apparent to thoseskilled in the art. As used in the specification and in the claims, thesingular form “a,” “an,” and “the” may include plural referents unlessthe context clearly dictates otherwise.

The present disclosure includes detailed descriptions of embodimentsthat allow for real-time monitoring of patient anatomy during varioustypes of medical treatments. For example, disclosed embodiments caninclude a device and/or a process for performing high temporal- andspatial-resolution magnetic resonance imaging (MRI) of the anatomy anddisease of a patient during various forms of medical therapy, which caninclude, for example, radiation therapy and/or various types of surgicalprocedures. Specific, non-limiting embodiments disclosed herein includeembodiments that include radiation therapy systems and embodiments thatinclude surgical guidance systems.

Thus, according to some embodiments, a radiation therapy device and aprocess are provided for performing high temporal- andspatial-resolution MRI of the anatomy and disease of a patient duringintensity modulated radiation therapy (IMRT) to directly measure andcontrol the highly conformal ionizing radiation dose delivered to thepatient. In a beneficial embodiment, a radiation therapy systemcomprises an open MRI that allows for axial access with IMRT radiationbeams to the patient, a multileaf-collimator or compensatingfilter-based IMRT delivery system, and cobalt-60 teletherapy radiationsource or sources in a single co-registered and gantry-mounted system.

As mentioned, prior systems do not simultaneously image the internalsoft tissue anatomy of a person in real time during the delivery ofradiation therapy while the radiation beams are striking the patient.Rather, in prior systems, an image is generated prior to and/or afterthe radiation delivery, and these images do not reflect any movementand/or natural changes that may occur in the patient during radiationdelivery. As such, targeted radiation without the devices described heremay not be successful if, after taking an initial image, the portion ofthe body to be treated either changes in size naturally, or changes inlocation due to the shifting of the patient prior to treatment; i.e.,the occurrence of patient setup errors or errors in the geometry andalignment of the patients anatomy; physiological changes in the patient,such as weight loss or tumor growth and shrinkage; and organ motions inthe patient including, but not limited to, breathing motion, cardiacmotion, rectal distension, peristalsis, bladder filling, and voluntarymuscular motion.

Aspects of the present disclosure allow for a system and method thathelp to eliminate problems of prior systems by allowing for real-timeMRI of the patient substantially simultaneous to radiation delivery. Thetargeted radiation can be readjusted if the region to be treated suffersfrom any type of dosimetric error caused patient setup error,physiological change, and/or inter-fraction or intra-fraction organmotion. Many actions may be taken including, but not limited to:shifting the patient position to account for changes in size and/orposition of targets and anatomy; stopping treatment altogether to permitadditional calculations to be determined before restarting treatment orallow for the cessation of transitory motion; adding extra deliveryfractions to increase the probability of tumor control or limiting thenumber of delivery fractions to decrease the probability of side effect;any of the beneficial process embodiments previous described; andreoptimizing the IMRT treatment plan on a variety of time scales, e.g.,reoptimization for every delivery, every beam, or every segment in theIMRT plan is performed.

Real-time imaging as referred to herein can refer to repetitive imagingthat may be acquired fast enough to capture and resolve anyintra-fraction organ motions that occur and that can result insignificant changes in patient geometry during a medical treatment, forexample while a dose of radiation is being delivered. The data obtainedby real-time imaging can allow for the determination of the actual dosedeposition in the patient. This can be achieved by applying knowntechniques of deformable image registration and interpolation to sum thedoses delivered to the moving tissues and targets. This data can becollected over the course of an entire multi-session radiotherapytreatment program, where data is accumulated while the radiation beamsare striking the patient and delivering the radiation dose, therebyallowing for the quantitative determination of 3D in vivo dosimetry.Hence, the present disclosure enables an effective means of assessingand controlling, or eliminating, organ-motion related dose-deliveryerrors.

Reference is now made with specific detail to the drawings in which likereference numerals designate like or equivalent elements throughout theseveral views, and initially to FIG. 1.

In FIG. 1, an embodiment of the present disclosure includes an open MRI15 and an IMRT cobalt therapy unit 20. The system shown in FIG. 1 alsoincludes a means to perform IMRT in the IMRT cobalt therapy unit 20,such as an MFC or compensation filter unit, and a gantry 25 that may beused for rotating the IMRT cobalt therapy unit 20 while keeping the MRI15 stationary. A patient 35 is positioned on an adjustable, stationarycouch 30.

FIG. 2 shows the system in use, and where the gantry 25 has been rotatedapproximately 90 degrees clockwise relative to its position in FIG. 1.As such, the IMRT cobalt therapy unit 20 is in position to treat thepatient 35 in one of many selectable locations. FIG. 3 shows a top viewof the system shown in FIG. 1, and FIG. 4 shows a side view of thesystem shown in FIG. 1.

FIG. 5 shows a detailed schematic view of a co-registered isotopicradiation source with a multi-leaf collimator, which serves as anembodiment of the IMRT cobalt therapy unit in FIG. 1. A radioisotopicsource 115 is shown with a fixed primary collimator 120, a secondarydoubly-divergent multileaf collimator 125, and a tertiary multi-leafcollimator 130 for blocking interleaf leakage from the secondarymulti-leaf collimator 125. FIG. 6 shows a perspective view of thesecondary doubly-divergent multi-leaf collimator 125 and the tertiarymulti-leaf collimator 130. As mentioned, the tertiary multi-leafcollimator 130 is provided for blocking interleaf leakage from thesecondary multi-leaf collimator 125. FIG. 7 shows a beams-eye view ofthe radioisotopic source 115, the secondary doubly divergent multi-leafcollimator 125, and the tertiary multi-leaf collimator 130.

[A beneficial embodiment of the present disclosure can thus include acomputer-controlled cone-beam cobalt therapy unit 20, such as acobalt-60 therapy unit, equipped with a multileaf collimator or anautomated compensating filter system mounted on a rotational gantry 25along with an orthogonally mounted “Open” MRI unit 15. The IMRT cobaltunit 20 projects its cone-beam geometry radiation down the center of theopening of the axial open MRI unit 15. The IMRT cobalt unit 15 rotateson a gantry 25 axially (about the longitudinal (cranial-caudal) axis ofthe patient) about a patient 35. An adjustable treatment couch 30 may beused to support the patient 35 in a stationary position while the gantry25 rotates to change the beam angle.

The present embodiment can use cobalt teletherapy as the radiationtherapy. While some IMRT use a linear electron accelerator fordelivering a more penetrating radiation therapy, the accelerator itselfproduces a treatment beam that is highly variable in regards to thelevel of radiation emitted. As such, it becomes difficult to accuratelydetermine the amount of radiation that is being used on the patient andto coordinate the motion of an MLC for IMRT delivery. Gamma-rays areelectromagnetic radiation emitted by the disintegration of a radioactiveisotope and have enough energy to produce ionization in matter,typically from about 100 keV to well over 1 MeV. The most usefulgamma-emitting radioactive isotopes for radiological purposes are foundto be cobalt (Co 60), iridium (Ir 192), cesium (Cs 137), ytterbium (Yb169), and thulium (Tm 170). As such, the disintegration of a radioactiveisotope is a well-known phenomena and, therefore, the radiation emittedby cobalt teletherapy is more consistent and, therefore, easier tocalculate in terms of preparing a treatment regimen for a patient.

Enablement of the present embodiment's cobalt IMRT has been demonstratedvia computational analysis. Simulations have been performed of IMRTdelivery with a commercially available cobalt therapy unit and a MLC. A3D image-based radiation therapy treatment planning system with a cobaltbeamlet model was commissioned and validated using measured radiochromicfilm data from a Theratronics 1000C cobalt therapy unit. An isotropic4×4×4 mm³ dose voxel grid (effectively Shannon-Nyquist limited for 7-rayIMRT source penumbra) was generated. This beamlet model was fitted topublished data and validated with radiochromic film measurements of 1×1cm² beamlets formed by a Cerrobend block and measured using a previouslyreported methodology. The calculation depths were then determined forthe same voxels with standard three-dimensional ray-tracing of thestructures. Density scaling to the depths computed was used to betteraccount for tissue heterogeneities in the dose model. The CPLEX, ILOGConcert Technologies industrial optimization solver using animplementation of the barrier interior-point method with dense columnhandling for IMRT optimization was used to solve for optimal IMRT plans.Beamlet fluences were discretized for each beam angle to 5% levels forleaf sequencing. The resulting plan dose distribution and histogramswere computed by summing the dose values weighted by the deliverablediscretized intensities. Leaf-transmission leakage intensities wereconservatively estimated at 1.7% for otherwise zero intensity beamlets.Finally, standard methods of heuristic leaf-sequencing optimization tocreate delivery instructions for the treatment plans were employed. Weadopted the Virginia Medical College simultaneous integrated boost (SIB)target dose-level scheme as it is the largest maximum to minimumclinical prescription dose ratio advocated in the literature, making itthe most difficult dose prescription scheme to satisfy. Head-and-neckIMRT provides an excellent basis for testing IMRT optimization forseveral reasons: 1) there are well defined treatment goals of sparingsalivary glands and other structures while maintaining homogeneoustarget coverage; 2) attempting to achieve these goals tests IMRToptimization to its technical limits; and 3) a large phase I/IImulti-institutional trial, the Radiation Therapy Oncology Group (RTOG)'sH-0022 Phase I/II Study of Conformal and Intensity Modulated Irradiationfor Oropharyngeal Cancer, has defined a common set of planning criteria.The case examined was run with 7 equispaced beams having InternationalElectrotechnical Commission (IEC) gantry angles of 0°, 51°, 103°, 154°,206°, 257°, and 309°. The treatment planning system generated 1,289beamlets to adequately cover the targets from the seven beam angles, andthe 4 mm isotropic voxel grid generated 417,560 voxels. FIG. 8 and FIG.9 show results of the treatment. Note that our system normalized plansto ensure 95% coverage of the high dose target. FIG. 8 shows axial dosedistributions from the single head-and-neck IMRT case planned using thecommissioned cobalt beamlets. Excellent target coverage and tissuesparing may be observed. FIG. 9 shows the DVH data derived from the leafsequenced and leakage corrected plan (i.e., deliverable plan) using the4 mm voxels and 1 Gy dose bins. The cobalt source based IMRT created anexcellent IMRT treatment plan for a head-and-neck patient. The y-rayIMRT was able to clearly spare the right parotid gland (RPG) and keepthe left parotid (LPG) and right submandibular glands (RSMG) under 50%volume at 30 Gy, while covering more than 95% of the target volumes (CTVand GTV) with the prescription dose or higher. All other structures werebelow tolerance. The unspecified tissue (SKIN) was kept below 60 Gy,with less than 3% of the volume above 50 Gy. The optimization model usedwas the same as published in Romeijn et al. and was not modified for thecobalt beams. For sites with larger depths such as prostate and lung itis known in the art that the addition of extra beams or isocentersallows for the creation of treatment plans using cobalt IMRT that mayachieve the same clinical quality criteria as linac-based IMRT. Thisenabling demonstration shows that a cobalt therapy unit is capable ofproviding high quality IMRT.

Enablement of the present embodiment's dose computation for cobalt IMRTin the presence of the magnetic field has been demonstrated viacomputational analysis. In addition, by using cobalt teletherapy, bettercalculations can be made based upon the magnetic field of the MRI. Whenthe radiation therapy is performed while the patient is stationed withinthe MRI, the magnetic field will cause a slight deflection of thetargeted radiation. As such, the calculations used to determine thetreatment regimen need to take this deflection into account. A chargedparticle moving in a vacuum at a velocity, v, in the presence of amagnetic field, B, experiences a Lorentz force given by F=v×B. Thisforce is not significant enough to significantly change the physics ofthe interactions of ionizing photons and electrons with matter; however,it may influence the overall transport of ionizing electrons and hencethe resulting dose distribution. The impact of magnetic fields on thetransport of secondary electrons has been well studied in the physicsliterature, starting more than 50 years ago. Recent studies haveemployed Monte Carlo simulation and analytic analysis in an attempt touse a localized magnetic field to help focus or trap primary orsecondary electrons to increase the local dose deposition in thepatient. All of these studies have examined aligning the direction ofthe magnetic field lines along the direction of the beam axis tolaterally confine the electron transport with the Lorentz force (called“longitudinal” magnetic fields, where the term longitudinal refers tothe beam and not the patient). For high field MRI, with magnetic fieldsbetween about 1.5-3.0 T is known that the initial radius of gyration issmall with respect to the MFP of large-angle scattering interactions forthe secondary electrons (bremsstrahlung, elastic scatter, and hardcollisions) and this condition results in the desired trapping orfocusing of the electrons. As the electrons lose energy the radiusdecreases as it is proportional to |v| and, in the absence oflarge-angle scattering interactions (CSDA) the electrons would follow aspiral with decreasing radius until they stop. Although this spiralingmay change the fluence of electrons it is known that it does not produceany significant synchrotron radiation. In the present embodiment, themagnetic field is preferably orthogonal to the radiation beams in orderallow parallel MRI for real-time imaging. Recent work has shown that a1.5 T magnetic field perpendicular to the beam axis of a 6 MV linac beammay significantly perturb the dose distribution to water for a 6 MVlinac beamlet. Both to avoid such dose distribution distortions and toprevent MRI artifacts that could compromise the spatial integrity of theimaging data, a beneficial embodiment of the present disclosure uses alow field open MRI design that allows the magnetic field to be directedalong the superior-inferior direction of the patient (see FIG. 1).Simple estimates of the radii of gyration for secondary electrons fromcobalt y rays indicate that the radii of gyration are much greater thanthe MFP for large-angle scattering interactions for electrons. This iseasily understood as the Lorentz force is proportional to the magnitudeof the magnetic field, |B| and the radius of gyration is inverselyproportional to the magnetic field. We have pursued modeling a beamletfrom a cobalt y-ray source in a slab phantom geometry using thewell-validated Integrated Tiger Series (ITS) Monte Carlo package and itsACCEPTM subroutine for transport in magnetic fields. For the simulationswe employed 0.1 MeV electron and 0.01 MeV photon transport energycutoffs, the standard condensed history energy grid (ETRAN approach),energy straggling sampled from Landau distributions, mass-collisionalstopping powers based on Bethe theory, default electron transportsubstep sizes, and incoherent scattering including binding effect. Threepairs of simulations were run where each pair included the run with andwithout a 0.3 T uniform magnetic field parallel to the beam direction. A2 cm circular cobalt y-ray beamlet was modeled on the followinggeometries: a 30×30×30 cm³ water phantom; a 30×30×30 cm³ water phantomwith a 10 cm lung density (0.2 g/cc) water slab at 5 cm depth; and a30×30×30 cm³ water phantom with a 10 cm air density (0.002 g/cc) waterslab at 5 cm depth. Simulations were run with between 30 and 100 millionhistories on a P4 1.7 GHz PC for between 8 and 30 hours to obtain lessthan a percent standard deviation in the estimated doses. The resultsare displayed in FIGS. 10-12. FIG. 10 clearly demonstrates that a 0.3 Tperpendicular uniform magnetic field, as would exist in a beneficialembodiment of the current disclosure, will not measurably perturb thedose distribution in soft tissue or bone. A very useful treatment sitefor the present embodiment will be lung and thorax, which contain themost significant tissue heterogeneities in the body. As seen in FIG. 11,adding a 12 cm lung density (0.2 g/cc) water slab to the phantom causesa very small yet detectable perturbation in the dose at the interfacesof the high and low density regions. These perturbations are smallenough to allow acceptable clinical application without correction. InFIG. 12, we finally observe significant perturbations, which existlargely in the low-density and interface regions. This demonstrates thatair cavities will hold the greatest challenge for accurate dosimetry.However, other than at interfaces with lower density media there shouldbe no significant perturbations in soft tissue and bone (where the MFPshortens even more than soft tissue). This data demonstrates that in abeneficial embodiment of the present disclosure with a low (0.2-0.5Tesla) field MRI, dose perturbation will be small except inside of aircavities were accurate dosimetry is not required due to an absence oftissue. By using a known radiation source, such as a cobalt teletherapyunit, the amount of deflection may be easily determined if the strengthof the MRI field is known. However, even if the strength of the field isknown, if a linear accelerator is used, the unknown energy spectrum ofthe radiation makes the calculations much more difficult.

Alternate sources of radiation that do not interfere significantly withthe operations of the MRI unit such as protons, heavy ions, and neutronsthat are produced by an accelerator or reactor away from the MRI unitand transported by beam to patient can also be included in alternativeembodiments.

In addition, the strength of the MRI field will factor into thecalculations and, as a result, the use of open MRIs offers advantagesover closed MRIs. In an open MRI, the strength of the field generated isgenerally less than the field of a closed MRI. As such, the imagesresulting from an open MRI have more noise and are not as clear and/ordefined as images from a higher field closed MRI. However, the strongerfield of the closed MRI causes more of a deflection of the radiationtreatment than the weaker field of an open MRI. Accordingly, dependingon the characteristics most beneficial to a given treatment regimen, aclosed MRI could alternatively be used. However, due to ease ofcalculation and/or the fact that a slightly less clear image duringtreatment is sufficient for adjusting most treatment regimens, an openMRI of the geometry shown in FIG. 1 is preferably used with the cobaltteletherapy to eliminate significant dose perturbations, prevent spatialimaging distortions, and allow for fast parallel phased array MRI.

By using an open MRI and cobalt teletherapy, three dimensional (3D)imaging of a patient can be accomplished during the radiation therapy.As such, by using the 3D images of the target region and the planningimages of the target region, a displacement can be determined that canbe updated based upon the continuous 3D images received during theradiotherapy process. Using the information obtained, the patient maythen be then translated relative to the treatment beam to reduce thedisplacement during the irradiation process, such as if the measureddisplacement is outside a predetermined limit. Irradiation may thencontinue after translation. Alternatively, the treatment beam may bemoved. The translation may occur during treatment or treatment may bestopped and then translation may occur.

By using 3D images during treatment and using these images to rapidlyposition and/or adjust the patient during the radiotherapy process,treatment accuracy may be substantially improved. If the patient becomesmisaligned while radiation is being applied, the misalignment may bemitigated through positional adjustment. In addition to possible doseescalation, improved positional accuracy permits treatment of tumorsthat are currently considered not treatable with radiation usingconventional systems. For example, primary spinal cord tumors and spinalcord metastases are typically not treated by conventional radiationsystems due to the high accuracy needed to treat lesions in suchimportant functional anatomic regions. The increased precision providedby 3D imaging during treatment makes it feasible to treat these types oftumors. Improvements are also expected for targets located in the lung,upper thorax, and other regions where intra-fraction organ motions areknown to cause problems with radiotherapy dosimetry.

In an alternative embodiment, a separate guidance system can be used totrack the patient location. The guidance system can be used to correlatethe actual patient position with the imaging information obtained duringboth planning and radiotherapy. This may significantly improve the easeof patient positioning by providing updateable image correlation andpositioning information throughout the patient set-up and treatmentdelivery phases, even when the patient is moved to positions that arenot perpendicular to the coordinate system of the therapy machine. Thisability to monitor patient position at non-coplanar treatment positionsmay be a significant improvement over conventional radiotherapy systems.In one beneficial embodiment, the guidance system may include anadjustable bed or couch for the patient to be placed upon. In analternative beneficial embodiment, the guidance system may include agantry that permits substantially simultaneous movement of the MRI andthe cobalt therapy unit. Some beneficial embodiments include both thegantry and the adjustable bed or couch.

The initial radiation treatment and/or any changes to the treatmentregimen can be determined based upon the use of a computer program thattakes into account various factors including, but not limited to, thearea of the patient to be treated, the strength of the radiation, thestrength of the MRI field, the position of the patient relative to theradiation unit, any change in the patient during treatment, and/or anypositional changes necessary of the patient and/or the radiation unitduring treatment. The resulting IMRT is then programmed and thetreatment is started.

One embodiment for determining a treatment plan for intensity modulatedradiation treatment (IMRT) includes dividing a three dimensional volumeof a patient into a grid of dose voxels, wherein each dose voxel is toreceive a prescribed dose of radiation from a plurality of beamlets eachhaving a beamlet intensity, and providing a convex programming modelwith a convex objective function to optimize radiation delivery. Themodel is solved to obtain a globally optimal fluence map, the fluencemap including beamlet intensities for each of the plurality of beamlets.This method is described in greater detail in U.S. Patent ApplicationPublication No. 2005/0207531, filed Jan. 20, 2005, titled “RADIATIONTHERAPY SYSTEM USING INTERIOR-POINT METHODS AND CONVEX MODELS FORINTENSITY MODULATED FLUENCE MAP OPTIMIZATION,” which is herebyincorporated herein by reference.

In general, the method used for determining a treatment plan, in onebeneficial embodiment, is the interior point method and variantsthereof. This method is beneficial due to its high efficiency andresulting generally short computational times. The interior point methodis described in a book by Steven J. Wright entitled “Primal-DualInterior-Point Methods” (SIAM, Publications, 1997, ISBN 089871382X).Primal-dual algorithms have emerged as the most beneficial and usefulalgorithms from the interior-point class. Wright discloses the majorprimal-dual algorithms for linear programming, including path-followingalgorithms (short- and long-step, predictor-corrector),potential-reduction algorithms, and infeasible-interior-pointalgorithms.

Once the treatment plan is determined, the clinician is able to ensurethat the treatment plan is followed. The patient to be treated is placedin the MRI. An image of the area to be treated is taken and the MRIcontinues to transmit a 3D image of the area. The treatment plan isinput into the cobalt radiation teletherapy unit and treatmentcommences. During treatment, a continuous image of the area beingtreated is observed. If the location of the area to be treated changes,such as if the patient moves or the area to be treated changes in size,the treatment plan is recalculated and/or the patient or radiation unitis adjusted without interrupting treatment. Alternatively, treatment canbe stopped, then the treatment plan can be recalculated, and then theposition of the patient and/or the radiation unit can be readjustedbefore recommencing treatment.

Multiple process embodiments may be used in improving the accuracy ofthe patient's therapy. One process embodiment can include taking the MRIdata and applying methods known in the art for deformable imageregistration and dose calculation to the delivered IMRT cobalt unitfluences to determine the dose delivered to the target and criticalstructures during each delivery fraction. Corrections to the patient'streatment could then be taken to add or subtract delivery fractions toimprove tumor control or reduce side effects, respectively. Along withthe dosimetric assessment, the size and progression of the patient'sdisease would also be assessed on a daily basis.

A second process embodiment can include taking the MRI data andperforming a reoptimization of the IMRT treatment plan before eachsingle radiation delivery to improve the accuracy of the treatmentdelivery. This process can be combined with the previous process toassess the dose delivered to the target and critical structures duringeach delivery fraction.

A third process embodiment can include taking the MRI data andperforming a reoptimization of the IMRT treatment plan on a beam-by-beambasis before the delivery of each radiation beam in a single radiationdelivery to improve the accuracy of the treatment delivery. This processcan include that the first process be performed rapidly before each beamdelivery.

A fourth process embodiment can include taking the MRI data andperforming reoptimization of the IMRT treatment plan on amoment-by-moment basis during the delivery of each part of eachradiation beam in a single radiation delivery to improve the accuracy ofthe treatment delivery. This process can also include that the firstprocess be performed in real-time simultaneously with the radiationdelivery. The process can include the use of parallel computation thatemploys one or more computers beneficially connected via a low latencylocal network or a secure connection on a wide area network to greatlyenhance the speed of the algorithms known in the art for MRI imagereconstruction, deformable image registration, dose computation, andIMRT optimization.

According to alternative embodiments, a surgical guidance device and aprocess are provided for performing temporal- and spatial-resolution MRIof the anatomy and disease of a patient during various types of surgicalprocedures. Descriptions above of imaging systems for radiationtreatment systems are also applicable to the following embodiments thatinvolve surgical guidance systems. In a beneficial embodiment, asurgical guidance system comprises an open MRI that allows for access tothe patient for performance of a surgical procedure, be it performed bya surgeon or by an automated device, such as a surgical robotic device.

Referring to FIG. 13, an embodiment of a surgical guidance system 200includes an MRI unit 210, or an alternative imaging source, thatpreferably allows for noninvasive and nonionizing radiation-basedimaging of a patient's internal anatomy. FIG. 13 also shows an imageprocessing unit 220, which can optionally be used to receive datagenerated by the MRI unit 210 and provide real-time image processing forconverting the data into images that can be used for monitoring patientanatomy. The information produced by the image processing unit 220 canbe provided to a control unit 230. Alternatively, data taken directlyfrom the MRI unit 210, which may be referred to herein as “image data,”may be interpreted or analyzed directly using methods known in the artto detect motions or changes in anatomy before or without passing thedata to the image processing unit 220. The control unit 230 can receiveinformation about a planned or ongoing surgical procedure from thesurgeon or other personnel via a planning interface 235. The controlunit 230 can optionally also receive information about an ongoingsurgical procedure by receiving information about a trackable surgicalinstrument 240 and/or an automated surgical robotic device 250 via atracking unit 260. Additionally, or alternatively, the control unit 230can infer information about an ongoing surgical procedure based onimagery provided from the image processing unit 220. The control unit230 can provide information to personnel monitoring the surgicalprocedure via an alert unit 270. Information provided via the alert unit270 can include information indicative of one or more pre-definedconditions, and the information can be provided in one or more of avariety of different forms including, but not limited to, visualinformation and/or audible information. The visual information caninclude, for example, images and/or textual information. The audibleinformation can include, for example, synthesized voice, voicerecordings, and/or alarms.

The units depicted in FIG. 13 and described herein are for purposes ofillustrating various functions, and as such the various units are notnecessarily representative of separate elements. For example, a computeror other processor-based system can be used for performing theoperations described herein of one or more of the image processing unit220, the control unit 230, the planning interface 235, the tracking unit260, and/or the alert unit 270. Also, one or more of the imageprocessing unit 220, the control unit 230, the planning interface 235,the tracking unit 260, and/or the alert unit 270 can be integrallycombined as a single device and/or can be integrally combined with theMRI unit 210.

The present disclosure thus includes a surgical guidance system formonitoring and/or guiding surgical interventions using noninvasive andnon-ionizing radiation-based imaging by an MRI unit 210 or the like. TheMRI unit 210 provides rapid volumetric imaging. The resulting images canbe processed using deformable image registration in order to provide forreal-time volumetric imaging, for example so that one can see a heartbeat, lungs expand and contract, organ movement, arteries, formation ofblood pools, etc. The real-time imaging can then be monitored bycomputerized control unit 230, which can continually analyze the imagingdata in real time, determine if there are risks or deviations from thesurgical plan, and if so, issue appropriate warnings or alerts to thesurgeon and/or other personnel via the alert unit 270.

As shown in FIG. 14, the MRI unit 210 can include a split main magnet,where each have of the main magnet is housed in a respective one of thefirst and second main magnet housings 280 a and 280 b. The MRI unit 210can also include split gradient coils, split RF shield, split T/R coil,and/or T/R surface coils (not shown). For example, the MRI unit 210 caninclude coils and/or shielding as disclosed in copending U.S. patentapplication Ser. No. 12/951,976, filed Nov. 22, 2010, titled“SELF-SHIELDED GRADIENT COIL,” which is hereby incorporated herein byreference.

The split-magnet MRI unit 210 can image the anatomy of a patient,particularly the portions of the patient's anatomy that are positionedin the gap between the first and second main magnet housings 280 a and280 b. The split-magnet MRI unit 210 also allows unobstructed access tothe region of the patient being imaged (inside the imaging field ofview) simultaneously to the performance of the surgical procedure. Thisallows the MRI unit 210 to continuously image the patient as surgery isbeing performed, where the images are of the region of the patient wherethe surgery is being performed. This also allows the surgical guidancesystem 200 to image a patient during surgery, as the surgical procedureis being performed, without repositioning the patient and/or imagingequipment.

A non-limiting example of a use of the surgical guidance system 200 caninvolve the use of the surgical guidance system 200 in connection with asurgical procedure. The process can begin with the surgical procedurebeing planned and images being acquired on as many high-resolutionimaging devices as can be useful to the procedure (e.g., PET-CT, SPECT,3 or 7 T MRI, etc.), as well as on the system 200 just before thesurgical procedure commences. These image sets can be fused via adeformable image registration algorithm to form a primary planning imageset.

The planning interface 235 provides a means for the surgeon, clinician,or other personnel to prepare a surgical plan. The planning interface235 can include, for example, a computer or other processor-basedsystem. In some embodiments, the planning interface 235 can includeknown surgical planning software and/or surgical planning capabilities.The planning interface 235 can include a keyboard, touch-screen,cursor-control device (e.g., trackball or mouse), or other such meansfor allowing a user to prepare a surgical plan. The planning interface235 can then provide the surgical guidance system 200 with surgicalparameters based on the surgical plan. The surgical plan thus willpreferably include parameters that should be monitored by the system 200during the surgical procedure. The parameters can vary depending onseveral factors, and can include threshold values that, if satisfied,can cause the system 200 to issue an alert via the alert unit 270.

For example, using the planning interface 235, the surgeon can definesegmented anatomy for protection, resection, anastomosis, etc. The MRIunit 210 and image processing unit 220 can produce high-quality planningscans that are displayed by the planning interface 235. A clinician caninteract with the planning scans using the planning interface 235 tocreate a plan for segmenting anatomy, set targets for excision, plan ananastomosis procedure, or any of many other known surgical procedures.Also, the planning interface 235 can be used to define surgical pathwaysas regions that represent routes that the surgeon intends to follow forentering the patient's body with surgical instruments. The planninginterface 235 can be used to mark organs as targets of the surgicalprocedure (e.g., a tumor may be marked for excision). The planninginterface 235 can be used to mark margins around organs for the surgicalprocedure (e.g., margins may be marked around a tumor for excision). Theplanning interface 235 can be used to define the extent of allowablepuncture or penetration into an organ. The planning interface 235 can beused to mark organs or regions for preservation from invasion bysurgical instruments (e.g., regions containing major nerves or arteriescan be marked for preservation). The planning interface 235 can be usedto define the volume of tissue to be resected, including margins ifrequired. Any of these and other surgical planning parameters can bedefined using the planning interface 235 and electronically stored as asurgical plan for the surgical procedure. It will be appreciated thatthese parameters include alert threshold values that can be expresslyindicated by a surgeon, clinician, or other personnel using the planninginterface 235, and/or can include alert threshold values that areinferred by the planning interface 235 based on planning informationthat is input into the planning interface 235 by a surgeon, clinician,or other personnel.

For example, a surgical plan can be created for a surgery to resect atumor, which may include removal of a portion of a kidney. Pre-surgicalimages of the region surrounding the tumor can be provided to theplanning interface 235. The surgeon can interact with the planninginterface 235 to identify the portion of the kidney to be removed, forexample by circling, marking, or otherwise identifying the portion to beremoved. The surgeon may also observe a potentially hazardous region,such as a nearby artery that should be avoided. The surgeon can thenalso identify the artery, again by circling, marking, or otherwiseidentifying the artery using the planning interface 235. The surgeon canalso use the planning interface 235 to identify other nearby organs, forexample the liver and bowel, that the surgeon does not want to damage.All of this information can then become part of the surgical plan thatwill be monitored by the surgical guidance system 200 during thesurgery. In this example, the surgical guidance system 200 would monitorthe surgery in real time and issue alerts if the surgeon nears theartery or the bowel, or if the surgeon is at or near the limit of theamount of kidney to be removed. The surgical guidance system 200 canalso watch for other conditions, such as pooling blood, irregular heartbeating, or irregular breathing. Also, since the surgical guidancesystem 200 can track the movement of tissue using volumetric, deformableimage registration imaging in real time during surgery, the control unit230 can track movement of the tissue associated with the tumor as thesurgeon is operating in order to allow the surgeon to stay on thesurgical path and ensure that all of the tumor is safely removed.

Thus, the surgical guidance system 200 can allow a surgeon to input aplan for a surgery, and then track the surgery in real time and alertthe surgeon as to their progress, for example if they are about to orhave just violated some requirement or safety constraint. In order toaccomplish this, the parameters that are defined using the planninginterface 235 can be monitored by the control unit 230. Also, oralternatively, the control unit 230 can monitor predefined or defaultparameters that may not necessarily be specified via the planninginterface 235. For example, the control unit 230 can be configured tomonitor surgical procedures for undesirable conditions, such asexcessively large motions, pooling of blood, and/or lack of blood flow.The control unit 230 can track organ motion and identify such conditionsas blockages or blood pooling based on changes in data received from theMRI or images received from the image processing unit 220 through, forexample, using known algorithms for detecting and/or tracking variationsin image intensity and/or data representative of patient anatomy.

During the surgical procedure, the control unit 230 can continuouslyreceive data representative of real-time images of patient anatomygenerated by the MRI unit 210 and, optionally, image processing unit220. The control unit 230 can monitor the parameters of the surgicalplan using the received image data and deformable image registrationduring the surgical procedure to aid the surgeon in performing a safeand successful surgical procedure by alerting the surgeon or otherpersonnel in the event that one or more alert threshold values has beenmet or exceeded (e.g., a surgical tool is at or near a defined margin).

Thus, the surgical guidance system 200 allows for real-time MRI-basedguidance during surgical procedures. The surgical guidance system 200has the ability to perform fast volumetric and/or planar imaging duringsurgical procedures. Imaging may be performed by the image processingunit 220 at a spatial and temporal resolution that allows for thetracking of the movement and deformation of the patient's tissue duringthe surgical procedure. In some embodiments, the MRI unit 210 cangenerate MRI data, for example k-space data, and the image processingunit 220 can rapidly generate image data representative of images thathave been reconstructed based on the MRI data generated by the MRI unit210. In some embodiments, the image processing unit 220 can include, forexample, a computer or other processor-based system. Also, in someembodiments, the image processing unit 220 can include an imaging systemand/or operate according to image reconstruction methods as disclosed inU.S. Patent Application Publication No. 2010/0322497, filed Jun. 17,2010, titled “SYSTEM AND METHOD FOR PERFORMING TOMOGRAPHIC IMAGEACQUISITION AND RECONSTRUCTION,” which is hereby incorporated byreference. Volumetric imaging can thus be employed over the surgicalregion of the patient's body at a resolution that allows for determiningthe spatial location of the anatomy with the resolution required by thesurgeon. The temporal refresh rate for imaging is preferably acquired atthe rate of human reflex and response, i.e., between U and ⅕ of asecond. The rate can be lowered or raised to capture slower or fasterphysiological processes occurring in the patient. The imaging foranatomy tracking and monitoring can be of a lower signal to noise andspatial resolution than diagnostic imaging, and deformable imageregistration can be employed to correlate higher resolution, signal tonoise and contrast imaging to the real-time tracking images. Thus, insome embodiments, the quality of the pre-surgical images produced by theMRI unit 210 for creating the surgical plan can be of a higher qualitythan the images produced by the MRI unit 210 during the surgicalprocedure for real-time tracking.

The segmented anatomy and regions can optionally be continuously trackedand auto-contoured by the image processing unit 220 using deformableimage registration on the stream of real time image data based on MRIdata generated by the MRI unit 210. Anatomy that is defined to becritical for sparing of damage, incision, or excision, can be monitoredwith low latency, e.g., less than a second, to warn the surgeon via thealert unit 270 with audible and/or visual signals of the risk ofdamaging the critical structure. Criteria for a safe procedure can berapidly computed and, if a violation is detected or is extrapolated tobe imminent, audio and visual warnings can be provided to the surgeon orother personnel. If requested or required, planar images and metrics canbe displayed to show the surgeon or other personnel what issues arecausing the alarm. In some embodiments, the alert unit can includedisplay means for continuously displaying images based on image datagenerated by the MRI unit 210 and image processing unit 220, therebyallowing the surgeon or other personnel to monitor the progress of thesurgical procedure. The control system 230 and/or alert unit 270 can beconfigured such that characteristics of alerts can change based on thetype and/or severity of the conditions that triggered the alert. Forexample, sounds, symbols, colors, or other indicators issued by thealert unit 270 can vary such that the degree of a warning issued by thealert unit can be increased with increases in the extent of damage,penetration, or excision of an organ in question.

As illustrated in FIG. 13, the surgical guidance system 200 can includea tracking unit 260 configured for tracking one or more surgicalinstruments 240. Referring to FIG. 14, it should be appreciated that alarge magnetic field is present at the location where the surgicalprocedure is taking place due to the ongoing MRI imaging that isoccurring during the surgical procedure. Thus, any surgical instrument240 used during a surgical procedure should be formed of materials thatare very weakly, or not significantly, affected by being placed in thepresence of an externally applied magnetic field, e.g., paramagneticmaterials. However, in some embodiments, the surgical instruments 240can include markers, or otherwise be visible to the MRI unit 210. Theposition of a surgical instrument 240 can then be distinguished andtracked by the control unit 230 based optionally on the appearance ofthe surgical instrument 240 in images generated by the image processingunit 220. Alternatively, the position of the surgical instrument 240 canbe inferred based on such things as organ motion and/or deformation,and/or other changes to the appearance of anatomical structures thatappear in the images generated by the MRI unit 210 where such changesare indicative of surgical intervention. In some embodiments, inaddition to continuous monitoring of a surgical instrument 240, thecontrol system 230 can detect deviations from a surgical path that waspreviously defined using the planning interface 235, and compute a newtrajectory, which can then be visually and/or audibly relayed to thesurgeon.

It will thus be appreciated based on the present disclosure that thedisclosed devices and methods have the ability to account fordeformations and motions of the patient's anatomy during surgery throughreal-time imaging. This ability is advantageous, since most organs inthe human body inherently and naturally experience motions continuously.The surgical instrument itself can also cause deformations anddisplacements of organs during the procedure as it punctures, cuts, orpresses against the patient's tissues. The disclosed devices and methodsalso have the ability to provide warnings to a surgeon, withoutnecessarily requiring the surgeon to regularly watch a monitordisplaying images. In addition, pointing devices are not required tofind the “correct” plane or projection in which to view a procedure.

As shown in FIG. 15, an automated surgical robotic device 250 can alsobe employed for performing a surgical procedure with, or in place of, asurgeon. For example, surgical robotic devices are known that can beused for performing a surgical procedure, including robotic deviceshaving varying degrees of automation. The surgical guidance system 200can provide feedback as described above to an operator and/or to therobotic device 250 during a surgical procedure. As discussed above, thefeedback can include alerts based on a surgical plan input via theplanning interface 235. The feedback can also include data used tocontrol a surgical path of the robotic device 250. It will beappreciated that the surgical robotic device 250 can be any type ofmedical robot, and should preferably be capable of operating within amagnetic resonance imaging (MRI) scanner for the purpose of performingor assisting in image-guided interventions.

Although the illustrative embodiments of the present disclosure havebeen described herein with reference to the accompanying drawings andexamples, it is to be understood that the disclosure is not limited tothose precise embodiments, and various other changes and modificationsmay be affected therein by one skilled in the art without departing fromthe scope or spirit of the disclosure. All such changes andmodifications are intended to be included within the scope of thedisclosure as defined by the appended claims.

What is claimed is:
 1. A surgical guidance system, comprising: amagnetic resonance imaging (MRI) system configured for generating MRIdata representative of a portion of a patient; a planning interface forgenerating a surgical plan based at least in part on pre-surgical imagesand input information regarding surgical parameters for a surgicalprocedure, the surgical parameters including one or more position basedparameters and one or more non-position based parameters; a control unitfor receiving image data based on the MRI data acquired during thesurgical procedure and for monitoring the image data for conditionsincluded in the surgical parameters of the surgical plan; and an alertunit for issuing an alert based on instructions from the control unit,wherein the control unit is configured to instruct the alert unit toissue the alert based on detecting at least one of the conditionsincluded in the surgical parameters of the surgical plan.
 2. Thesurgical guidance system of claim 1, wherein the MRI includes first andsecond main magnets separated by a gap.
 3. The surgical guidance systemof claim 1, wherein the MRI is configured such that images are capturedsubstantially simultaneously with performance of the surgical procedure.4. The surgical guidance system of claim 3, wherein the control unit isconfigured to employ the image data for monitoring a patient's responseto the surgical procedure substantially simultaneously with performanceof the surgical procedure.
 5. The surgical guidance system of claim 4,wherein the monitoring of the patient's response to the surgicalprocedure includes monitoring changes to a patient's anatomysubstantially simultaneously with performance of the surgical procedure.6. The surgical guidance system of claim 5, wherein the control unit isconfigured to instruct the alert unit to issue the alert during thesurgical procedure based on detecting at least one condition associatedwith the changes to the patient's anatomy.
 7. The surgical guidancesystem of claim 1, further comprising a tracking unit for tracking asurgical instrument used for performing the surgical procedure.
 8. Thesurgical guidance system of claim 1, further comprising a tracking unitfor tracking a surgical robotic device performing the surgicalprocedure.
 9. The surgical guidance system of claim 1, wherein the alertunit is configured to issue the alert in the form of at least one ofvisual information and audible information.
 10. The surgical guidancesystem of claim 1, further comprising an image processing unit forreceiving the MRI data from the MRI system and generating the image databased on the MRI data.
 11. The surgical guidance system of claim 10,wherein the MRI system is configured for: obtaining MRI datarepresentative of a first quality of images before the start of thesurgical procedure; and obtaining MRI data representative of a secondquality of images during substantially simultaneous performance of thesurgical procedure, the second quality being lower than the firstquality.
 12. The surgical guidance system of claim 11, wherein the imageprocessing unit is configured for generating image data representativeof volumetric images from MRI data generated during the obtaining of MRIdata representative of the second quality of images, and wherein thegenerating of the image data representative of volumetric imagesincludes using deformable image registration.
 13. The surgical guidancesystem of claim 10, wherein the image processing unit is configured forgenerating image data representative of volumetric images based on theMRI data received from the MRI system.
 14. The surgical guidance systemof claim 13, wherein the image processing unit is configured forgenerating the image data representative of volumetric images usingdeformable image registration.
 15. A surgical guidance system of claim1, wherein the one or more non-position based parameters include anextent of allowable penetration into an organ, an allowable volume oftissue to be resected, an allowable amount of organ motion, and anallowable amount of blood pooling.
 16. The surgical guidance system,comprising: a magnetic resonance imaging (MRI) system configured forgenerating MRI data representative of a portion of a patientsubstantially simultaneously with performance of a surgical procedure onthe patient; a control unit for receiving image data representative ofvolumetric images based on the MRI data acquired during the surgicalprocedure and for monitoring the image data for predeterminedconditions, the predetermined conditions associated with one or moreposition based parameters and one or more non-position based parameters;and an alert unit for issuing an alert based on instructions from thecontrol unit, wherein the control unit is configured to instruct thealert unit to issue the alert based on detecting at least one of thepredetermined conditions.
 17. The surgical guidance system of claim 16,further comprising a planning interface for receiving at least one ofthe predetermined conditions.
 18. The surgical guidance system of claim16, wherein the MRI is configured such that MRI data is capturedsubstantially simultaneously with performance of the surgical procedure.19. The surgical guidance system of claim 18, wherein the control unitis configured to employ the image data for monitoring a patient'sresponse to the surgical procedure substantially simultaneously withperformance of the surgical procedure.
 20. The surgical guidance systemof claim 19, wherein the monitoring of the patient's response to thesurgical procedure includes monitoring changes to a patient's anatomysubstantially simultaneously with performance of the surgical procedure.